These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12045239)

  • 1. CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.
    Ohlén C; Kalos M; Cheng LE; Shur AC; Hong DJ; Carson BD; Kokot NC; Lerner CG; Sather BD; Huseby ES; Greenberg PD
    J Exp Med; 2002 Jun; 195(11):1407-18. PubMed ID: 12045239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death by neglect as a deletional mechanism of peripheral tolerance.
    Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
    Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors.
    Teague RM; Sather BD; Sacks JA; Huang MZ; Dossett ML; Morimoto J; Tan X; Sutton SE; Cooke MP; Ohlén C; Greenberg PD
    Nat Med; 2006 Mar; 12(3):335-41. PubMed ID: 16474399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells.
    Merritt C; Enslen H; Diehl N; Conze D; Davis RJ; Rincón M
    Mol Cell Biol; 2000 Feb; 20(3):936-46. PubMed ID: 10629051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
    Ghorashian S; Veliça P; Chua I; McNicol AM; Carpenter B; Holler A; Nicholson E; Ahmadi M; Zech M; Xue SA; Uckert W; Morris E; Chakraverty R; Stauss HJ
    J Immunol; 2015 Feb; 194(3):1080-9. PubMed ID: 25539815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.
    Dhanji S; Teh SJ; Oble D; Priatel JJ; Teh HS
    Blood; 2004 Oct; 104(7):2116-23. PubMed ID: 15178577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent.
    Olurinde MO; Shen CH; Drake A; Bai A; Chen J
    Cell Mol Immunol; 2011 Sep; 8(5):415-23. PubMed ID: 21666707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.
    Vacchio MS; Hodes RJ
    J Exp Med; 2003 Jan; 197(1):19-26. PubMed ID: 12515810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
    Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
    J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Tissue-Specific CD8
    Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice.
    Otahal P; Schell TD; Hutchinson SC; Knowles BB; Tevethia SS
    J Immunol; 2006 Sep; 177(5):3089-99. PubMed ID: 16920946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
    Rausch MP; Hastings KT
    PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.
    Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A
    Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
    Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.